Inhibition of Clusterin Represses Proliferation by Inducing Cellular Senescence in Pancreatic Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-022-11668-0
Abstract: The outcome of pancreatic ductal adenocarcinoma (PDAC) is unsatisfactory, and the identification of novel therapeutic targets is urgently needed. Clinical studies on the antisense oligonucleotide that targets clusterin (CLU) expression have been conducted and have… read more here.
Keywords: clu; senescence; inducing cellular; cellular senescence ... See more keywords
Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective
Sign Up to like & getrecommendations! Published in 2019 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2019.00181
Abstract: Clinical studies with cellular therapies using tolerance-inducing cells, such as tolerogenic antigen-presenting cells (tolAPC) and regulatory T cells (Treg) for the prevention of transplant rejection and the treatment of autoimmune diseases have been expanding the… read more here.
Keywords: forward tolerance; inducing cellular; tolerance inducing; cellular therapies ... See more keywords